Android app Apple app link

Ligand Pharmaceuticals Incorporated (LGND) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$198.73
Day's range
$209.6

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/06/2026 H.C. Wainwright Joseph Pantginis $358.00 $313.55   14.18%
08/03/2026 Oppenheimer Leland Gershell $326.00 $287.54   13.38%
07/20/2026 Craig-Hallum Matt Hewitt $345.00 $303.03   13.85%
07/08/2026 Stifel Nicolaus Annabel Samimy $332.00 $319.43   3.94%
04/30/2026 H.C. Wainwright Joseph Pantginis $289.00 $224.86   28.52%
04/14/2026 H.C. Wainwright Joseph Pantginis $243.00 $231.11   5.14%
02/24/2026 H.C. Wainwright Joseph Pantginis $239.00 $190.86   25.22%
12/10/2025 Oppenheimer Trevor Allred $275.00 $185.83   47.98%
11/06/2025 Stifel Nicolaus Annabel Samimy $220.00 $208.22   5.66%
11/03/2025 Oppenheimer Leland Gershell $250.00 $192.97   29.55%
09/03/2025 Oppenheimer Leland Gershell $190.00 $165.76   14.62%
10/21/2024 H.C. Wainwright Joseph Pantginis $157.00 $108.31   44.95%
10/02/2024 Oppenheimer Leland Gershell $135.00 $99.95   35.07%
07/29/2024 RBC Capital Douglas Miehm $130.00 $108.75   19.54%
07/09/2024 Craig-Hallum Matt Hewitt $140.00 $86.88   61.14%
06/28/2024 H.C. Wainwright Joseph Pantginis $144.00 $82.33   74.91%

Ligand Pharmaceuticals, Inc. FAQ's

Ligand Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright, Oppenheimer, Craig-Hallum, RBC Capital, Stifel Nicolaus, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.